Literature DB >> 1908474

CBF measured by Xe-CT: approach to analysis and normal values.

H Yonas1, J M Darby, E C Marks, S R Durham, C Maxwell.   

Abstract

Normal reference values and a practical approach to CBF analysis are needed for routine clinical analysis and interpretation of xenon-enhanced computed tomography (CT) CBF studies. We measured CBF in 67 normal individuals with the GE 9800 CT scanner adapted for CBF imaging with stable Xe. CBF values for vascular territories were systematically analyzed using the clustering of contiguous 2-cm circular regions of interest (ROIs) placed within the cortical mantle and basal ganglia. Mixed cortical flows averaged 51 +/- 10ml.100g-1.min-1. High and low flow compartments, sampled by placing 5-mm circular ROIs in regions containing the highest and lowest flow values in each hemisphere, averaged 84 +/- 14 and 20 +/- 5 ml.100 g-1.min-1, respectively. Mixed cortical flow values as well as values within the high flow compartment demonstrated significant decline with age; however, there were no significant age-related changes in the low flow compartment. The clustering of systematically placed cortical and subcortical ROIs has provided a normative data base for Xe-CT CBF and a flexible and uncomplicated method for the analysis of CBF maps generated by Xe-enhanced CT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908474     DOI: 10.1038/jcbfm.1991.128

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  23 in total

Review 1.  CT perfusion cerebral blood flow imaging in neurological critical care.

Authors:  Mark R Harrigan; Jody Leonardo; Kevin J Gibbons; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease.

Authors:  Greg Zaharchuk; Huy M Do; Michael P Marks; Jarrett Rosenberg; Michael E Moseley; Gary K Steinberg
Journal:  Stroke       Date:  2011-07-28       Impact factor: 7.914

3.  Management of lateral skull base tumours.

Authors:  Prathamesh S Pai; Aliasgar Moiyadi; Deepa Nair
Journal:  Indian J Surg Oncol       Date:  2010-11-21

4.  Fast nonlinear regression method for CT brain perfusion analysis.

Authors:  Edwin Bennink; Jaap Oosterbroek; Kohsuke Kudo; Max A Viergever; Birgitta K Velthuis; Hugo W A M de Jong
Journal:  J Med Imaging (Bellingham)       Date:  2016-06-16

5.  Indications for cerebral revascularization for patients with atherosclerotic carotid occlusion.

Authors:  Colin P Derdeyn; Robert L Grubb; William J Powers
Journal:  Skull Base       Date:  2005-02

6.  Outcome prediction within twelve hours after severe traumatic brain injury by quantitative cerebral blood flow.

Authors:  Paul Kaloostian; Claudia Robertson; Shankar P Gopinath; Martina Stippler; C Christopher King; Clifford Qualls; Howard Yonas; Edwin M Nemoto
Journal:  J Neurotrauma       Date:  2012-03-20       Impact factor: 5.269

7.  Significance of a reduced cerebral blood flow during the first 12 hours after traumatic brain injury.

Authors:  Roman Hlatky; Charles F Contant; Pedro Diaz-Marchan; Alex B Valadka; Claudia S Robertson
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

8.  Xenon CT measurement of cerebral blood flow in hydrocephalus.

Authors:  P Maeder; N de Tribolet
Journal:  Childs Nerv Syst       Date:  1995-07       Impact factor: 1.475

9.  Perfusion Characteristics in Chronic Cerebrovascular Insufficiency : An Anatomically and Clinically Oriented XeCT Analysis of Cerebrovascular Atherosclerotic Disease.

Authors:  Gerrit Alexander Schubert; Marcel Seiz; Marcus Czabanka; Claudius Thomé
Journal:  Transl Stroke Res       Date:  2011-10-04       Impact factor: 6.829

10.  Cerebrovascular insufficiency as the criterion for revascularization procedures in selected patients: a correlation study of xenon contrast-enhanced CT and PWI.

Authors:  Gerrit Alexander Schubert; Carolin Weinmann; Marcel Seiz; Lars Gerigk; Christel Weiss; Peter Horn; Claudius Thomé
Journal:  Neurosurg Rev       Date:  2008-09-13       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.